Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Oleomorphocycline
RN: 18353-77-0
InChIKey: DTEPEKSPRVJSHL-RHEINJKJSA-N

Note

  • Combination of oleandomycin & morphocycline.

Classification Code

  • Drug / Therapeutic Agent

Molecular Formula

  • C35-H61-N-O12.x-C27-H33-N3-O9

Molecular Weight

  • 1231.43
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Oleomorphocycline

Synonym

  • Oleomorphocycline

Systematic Names

  • Oleandomycin, compd. with 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-N-(morpholinomethyl)-1,11-dioxo-2-naphthacenecarboxamide
  • Oleandomycin, mixt. with (4S-(4-alpha,4a-alpha,5a-alpha,6-beta,12a-alpha))-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-N-(4-morpholinylmethyl)-1,11-dioxo-2-naphthacenecarboxamide
  • Oleandomycin, mixt. with (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-N-(4-morpholinylmethyl)-1,11-dioxo-2-naphthacenecarboxamide

Registry Numbers

CAS Registry Number

  • 18353-77-0

System Generated Number

  • 0018353770

Molecular Formulas

Molecular Formula

  • C35-H61-N-O12.x-C27-H33-N3-O9

Molecular Formula Fragments

  • C27-H33-N3-O9
  • C35-H61-N-O12
  • COMPONENT

Structure Descriptors

InChI

1S/C35H61NO12.C27H33N3O9/c1-16-14-35(15-43-35)32(40)19(4)27(37)18(3)22(7)46-33(41)21(6)31(47-26-13-25(42-11)28(38)23(8)45-26)20(5)30(16)48-34-29(39)24(36(9)10)12-17(2)44-34;1-26(37)13-5-4-6-16(31)17(13)21(32)18-14(26)11-15-20(29(2)3)22(33)19(24(35)27(15,38)23(18)34)25(36)28-12-30-7-9-39-10-8-30/h16-31,34,37-39H,12-15H2,1-11H3;4-6,14-15,20,31,33-34,37-38H,7-12H2,1-3H3,(H,28,36)/t16-,17+,18-,19+,20+,21+,22+,23-,24-,25-,26-,27-,28-,29+,30-,31-,34-,35+;14-,15-,20-,26+,27-/m00/s1

InChIKey

DTEPEKSPRVJSHL-RHEINJKJSA-N

Smiles

C1([C@@]2(C(=C3C(c4c(cccc4[C@@]([C@H]3C[C@H]2[C@H](N(C)C)C(O)=C1C(=O)NCN1CCOCC1)(C)O)O)=O)O)O)=O.O1[C@H]([C@@H]([C@H](C[C@@H]1O[C@@H]1[C@H](C(O[C@@H]([C@@H]([C@@H]([C@H](C([C@@]2(OC2)C[C@@H]([C@@H]([C@H]1C)O[C@@H]1O[C@@H](C[C@@H]([C@H]1O)N(C)C)C)C)=O)C)O)C)C)=O)C)OC)O)C

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intravenous 160mg/kg (160mg/kg)   Pharmaceutical Chemistry Journal Vol. 6, Pg. 344, 1972.